Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06399172

OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy

Sponsor: OncoSil Medical Limited

View on ClinicalTrials.gov

Summary

The OSPRItaly Patient Registry has been developed to assess the performance and safety of the OncoSil™ device when used within the approved indication of unresectable, locally advanced pancreatic cancer, in combination with gemcitabine-based chemotherapy, within a real-world observational registry.

Official title: OncoSil Pancreatic Cancer Post-marketing Clinical Registry Italy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2024-05-30

Completion Date

2029-10-30

Last Updated

2024-05-03

Healthy Volunteers

No

Interventions

DEVICE

OncoSil

Intra-tumoural implantation